GNH USA

Europe — EMA

Oleunor N5e

GNH USA supplies Oleunor N5e (Glycine), an electrolyte solution for fluid and electrolyte replacement in dehydration, hypokalemia and related disorders.

Glycine, Magnesium Chloride Hexahydrate, Potassium Chloride, Calcium Chloride Dihydrate, L-Lysine Ac

Request sourcing

1
Pack/s

What is Glycine, Magnesium Chloride Hexahydrate, Potassium Chloride, Calcium Chloride Dihydrate, L-Lysine Ac?

Glycine, the active ingredient in Oleunor N5e, is an electrolyte solution presented as an intravenous solution for intravenous use. It helps replace essential electrolytes and supports fluid balance in patients who require intravenous electrolyte replacement, such as those with dehydration or electrolyte disturbances. It is formulated with magnesium chloride, potassium chloride, calcium chloride, and L‑lysine acetate to address multiple electrolyte deficits simultaneously.

GNH USA supplies Oleunor N5e as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company follows stringent quality standards and provides regulatory documentation for cross‑border distribution.

What is Glycine, Magnesium Chloride Hexahydrate, Potassium Chloride, Calcium Chloride Dihydrate, L-Lysine Ac used for?

Oleunor N5e is used to correct electrolyte imbalances and support fluid replacement in clinical settings.

- Dehydration: restores plasma volume and electrolyte concentrations in patients with fluid loss. - Hypokalemia: provides potassium chloride to raise low serum potassium levels. - Hypomagnesemia: supplies magnesium chloride to correct magnesium deficiency. - Hypocalcemia: delivers calcium chloride to normalize calcium levels.

What are the side effects of Glycine, Magnesium Chloride Hexahydrate, Potassium Chloride, Calcium Chloride Dihydrate, L-Lysine Ac?

Intravenous administration of Oleunor N5e may be associated with several adverse reactions.

Common Side Effects: - Infusion site irritation: redness, pain, or swelling at the catheter site. - Mild hyperkalemia: transient elevation of serum potassium. - Mild hypermagnesemia: transient elevation of serum magnesium. - Nausea or vomiting: gastrointestinal discomfort during infusion.

Serious or Rare Side Effects: - Severe hyperkalemia: can cause cardiac arrhythmias. - Anaphylactic reaction: sudden hypersensitivity requiring emergency treatment. - Cardiac arrest: due to extreme electrolyte disturbances.

What precautions apply to Glycine, Magnesium Chloride Hexahydrate, Potassium Chloride, Calcium Chloride Dihydrate, L-Lysine Ac?

When using Oleunor N5e, clinicians should observe the following precautions.

- Renal impairment: monitor electrolyte levels closely to avoid accumulation. - Cardiac disease: avoid rapid infusion rates that may precipitate arrhythmias. - Pregnancy: prescribe only if potential benefit justifies potential risk to the fetus. - Concomitant electrolyte supplements: adjust dosing to prevent excess. - Infusion rate: follow recommended administration guidelines to prevent fluid overload. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Glycine, Magnesium Chloride Hexahydrate, Potassium Chloride, Calcium Chloride Dihydrate, L-Lysine Ac interact with?

Oleunor N5e can interact with certain medications; awareness of these interactions helps maintain safety.

Major Interactions (Avoid): - Potassium‑sparing diuretics: increase risk of dangerous hyperkalemia. - Calcium channel blockers combined with high calcium load: may cause hypercalcemia. - Magnesium‑containing antacids or laxatives: can lead to excessive magnesium levels.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor serum potassium during therapy. - Loop diuretics: may exacerbate electrolyte shifts, requiring close monitoring. - Insulin therapy: insulin drives potassium into cells, potentially altering potassium balance.

Frequently asked questions

What is Oleunor N5e used for?+
Oleunor N5e is an intravenous electrolyte solution used to replenish essential electrolytes and restore fluid balance in patients who have experienced dehydration, electrolyte loss, or specific deficiencies such as low potassium, magnesium, or calcium levels.
How does the glycine in Oleunor N5e work?+
Glycine in Oleunor N5e serves as a carrier molecule that helps stabilize the solution and contributes to nitrogen transport. The primary therapeutic effect comes from the supplied ions—magnesium, potassium, calcium, and lysine acetate—which directly correct electrolyte deficits when infused into the bloodstream.
What is the usual dose of Oleunor N5e?+
The dose of Oleunor N5e is determined by the prescribing clinician based on the patient’s electrolyte measurements, fluid status, and overall clinical condition. Healthcare professionals calculate the required volume and infusion rate to safely correct the identified deficiencies.
Is Oleunor N5e safe to use during pregnancy or breastfeeding?+
Limited clinical data are available for use in pregnancy and lactation. It should be administered only when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.
How do I order Oleunor N5e from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.
How does Oleunor N5e compare with other electrolyte solutions?+
Oleunor N5e offers a balanced combination of glycine, magnesium, potassium, calcium, and L‑lysine acetate, providing a broader spectrum of electrolytes than some single‑ion solutions such as standard potassium chloride infusions. This multi‑ion formulation can simplify therapy when multiple deficiencies are present, though clinicians choose the product that best matches the patient’s specific electrolyte profile.
What are the storage and handling requirements for Oleunor N5e?+
Oleunor N5e should be stored at 2‑8 °C, protected from light, and kept in its original packaging. Do not freeze or shake the solution. Before use, inspect the container for any particulate matter or discoloration and allow the product to reach room temperature if required by the administration protocol.
How is Oleunor N5e administered?+
Oleunor N5e is administered intravenously, typically via a controlled infusion pump or gravity drip. The solution may be given undiluted or diluted according to institutional guidelines, and the infusion rate should be adjusted based on the patient’s cardiac status, renal function, and target electrolyte correction goals.
What are the most serious risks associated with Oleunor N5e?+
Serious risks include severe hyperkalemia or hypermagnesemia, which can lead to cardiac arrhythmias or cardiac arrest, and anaphylactic reactions. Continuous monitoring of electrolyte levels, cardiac rhythm, and patient symptoms during infusion helps mitigate these risks.
Who should not receive Oleunor N5e?+
Patients with known hypersensitivity to any component of the formulation, those with existing severe hyperkalemia, uncontrolled cardiac arrhythmias, or severe renal failure where electrolyte excretion is compromised should not receive Oleunor N5e unless a specialist determines it is absolutely necessary.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Glycine, Magnesium Chloride Hexahydrate, Potassium Chloride, Calcium Chloride Dihydrate, L-Lysine Ac
Route
Intravenous Use
Manufacturer
Noridem Enterprises Ltd
Origin
EU